HealthDay - FRIDAY, July 24 (HealthDay News) -- Eli Lilly's Forteo (teriparatide injection) has received expanded approval from the U.S. Food and Drug Administration to treat osteoporosis associated with long-term use of glucocorticoid medication, the company said Thursday.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.